glp-1 and general anesthesia drugs aspiration risk ASA: Hold GLP-1 Agonists Before

Focusing on FDA-approved medications In May 2025, Weight Watchers confirmed that it would not be offering compounded semaglutide prescriptions

The result is a dynamic ingredient that has been shown to promote skin healing, stimulate collagen production, and reduce the appearance of fine lines and wrinkles

Unlike proximal L cells stimulated by direct nutrient contact, these distal cells rely on short-chain fatty acids (SCFAs), secondary bile acids (BAs), and tryptophan-derived metabolites produced by commensal bacteria

Ongoing long-term outcome studies continue to refine the safety profile and inform clinical risk stratification